558 results on '"Faraci, Maura"'
Search Results
152. Evaluation of Clinical and Morphological Practices in the Diagnosis of Transplant-Associated Microangiopathy: A Study on Behalf of the Complications and Quality of Life Working Party of the EBMT
153. Long-term Outcome of a Successful Cord Blood Stem Cell Transplant in Mevalonate Kinase Deficiency
154. Intensive Care Unit Admission in Children With Malignant or Nonmalignant Disease
155. Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation
156. Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation
157. Role of Management Strategies in Reducing Mortality From Invasive Fungal Disease in Children With Cancer or Receiving Hemopoietic Stem Cell Transplant
158. Activity of linezolid and daptomycin against methicillin-resistant coagulase-negative staphylococci with increased MIC for vancomycin isolated from blood cultures in pediatric patients
159. Impact Of Prophylaxis With Defibrotide On The Occurrence Of Acute GvHD In Allogeneic HSCT
160. Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
161. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation
162. Successful dalbavancin use in preventing reactivation of Staphylococcus aureus liver abscess during pre-engraftment neutropenia after allogeneic hematopoietic stem cell transplantation.
163. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
164. Invasive mould infections in newborns and children
165. Magnetic resonance imaging in childhood leukemia survivors treated with cranial radiotherapy: A cross sectional, single center study
166. Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Cord Blood Transplantation (CBT). Retrospective Analysis on Behalf of Eurocord and the EBMT Autoimmune Diseases Working Party.
167. High Levels of β- d -Glucan in Immunocompromised Children with Proven Invasive Fungal Disease
168. Defibrotide (DF) for the Prevention of Hepatic Veno-Occlusive Disease (VOD) in Pediatric Stem Cell Transplantion: Results of a Prospective Phase II/III Randomized, Multicenter Study.
169. Incidence of Veno-Occlusive Disease with IV in Busulfan Children Is Higher Than Expected: Preliminary Results of the VOD-DF Trial.
170. LOW DOSAGE CIDOFOVIR WITHOUT PROBENECID AS TREATMENT FOR BK VIRUS HAMORRHAGIC CYSTITIS AFTER HEMOPOIETIC STEM CELL TRANSPLANT
171. Maintenance of Therapeutic Concentrations of Caspofungin after Temporary Treatment Interruption (48 Hours) in a Child with Invasive Aspergillosis
172. Intractable Epilepsy Secondary to Cyclosporine Toxicity in Children Undergoing Allogeneic Hematopoietic Bone Marrow Transplantation
173. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant
174. Cardiac and Pulmonary Function Late Effects after Bone Marrow Transplantation in Childhood: Prospective Study on Behalf of EBMT LEWP Group.
175. Surgery for Acute Graft-Versus-Host Disease of the Bowel: Description of a Pediatric Case
176. Spontaneous pregnancy after hematopoietic stem cell transplantation for chronic granulomatous disease.
177. Long-lasting Hypogammaglobulinemia Following Rituximab Administration for Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disease Preemptive Therapy
178. How to optimize outcome of patients undergoing HLA‐matched related haematopoietic stem cell transplantation in acquired and inherited bone marrow failure syndromes.
179. Successful dalbavancin use in preventing reactivation of Staphylococcus aureusliver abscess during pre-engraftment neutropenia after allogeneic hematopoietic stem cell transplantation
180. Autoimmune Hematological Diseases after Allogeneic Hematopoietic Stem Cell Transplantation in Children: An Italian Multicenter Experience.
181. Activity of linezolid and daptomycin against methicillin-resistant coagulase-negative staphylococci with increased MIC for vancomycin isolated from blood cultures in pediatric patients.
182. Haploidentical Stem Cell Transplantation After TCR-αβ+and CD19+Cells Depletion In Children With Congenital Non-Malignant Disease
183. Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group.
184. Colistin Area Under the Time- Concentration in Children Treated With Intravenous Loading Dose and Maintenance Therapy.
185. Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)
186. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.
187. Daclizumab in the management of steroid resistant/dependent acute gvhd in paediatric patients
188. Successful Treatment of Progressive Multifocal Leukoencephalopathy with JCV-Targeted T-Cell Therapy
189. PARTIAL RAG DEFICIENCY IN A CHILD WITH AUTOIMMUNE CYTOPENIA AND FEATURES OF AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS)
190. Treatment of the obliterant bronchiolitis in pediatric allogeneic recipients: Two periods compared
191. SINGLE/MULTI-LINEAGE BONE MARROW FAILURES SECONDARY TO PIDs-RELATED KNOWN/NOVEL MUTATIONS. A SINGLE CENTER EXPERIENCE
192. Weekly high-dose liposomal amphotericin B for secondary prophylaxis of invasive fungal disease in immunocompromised children: experience from a pediatric case series.
193. High Levels of ß-d-Glucan in Immunocompromised Children with Proven Invasive Fungal Disease
194. Pediatric cancer and hematopoietic stem cell transplantation patients requiring renal replacement therapy: results of the retrospective nationwide AIEOP study.
195. Hematopoietic Stem Cell Transplantation in ARPC1B Deficiency.
196. Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT.
197. Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.
198. Candida infections in paediatrics: Results from a prospective single-centre study in a tertiary care children's hospital.
199. Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents with Hematologic Malignancies: An AIEOP-GITMO Retrospective Multicenter Study.
200. Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.